Slope’s Post

How do you avoid key pitfalls in your clinical trial that lead to budget overruns and missed timelines? Implementing a clinical development plan (CDP) can serve as a critical roadmap in your early stages of product development, particularly for small to mid-sized biotech companies, the CDP can serve as a principal indicator of success. Read our newest blog to explore the importance of building a strong CDP and outline effective strategies for optimizing it: https://lnkd.in/gfmvezr7 #DrugDevelopment #ClinicalDevelopment #ClinicalTrials #Biotech #RegulatoryAffairs

Clinical development plans can serve as a critical factor in defining a strategic roadmap during early development. In this blog, we explore the key elements of a CDP and overarching strategies for optimizing these plans. Please reach out if you have any questions!

How do you avoid key pitfalls in your clinical trial that lead to budget overruns and missed timelines? Implementing a clinical development plan (CDP) can serve as a critical roadmap in your early stages of product development. Particularly for small to mid-sized biotech companies, the CDP can serve as a principal indicator of success on the path to developing new therapies that are safe and effective for the patients that need them. Read our newest blog, where Allucent experts, Sugato De, Joshua Taylor, PhD, RAC, Lisa S. Sanders, and John McIntyre, PhD explore the critical importance of building a strong CDP and outline effective strategies for optimizing that plan.   https://lnkd.in/gfmvezr7 #Allucent #BringNewTherapiesToLight #ClinicalDevelopment #Biotech #RegulatoryAffairs

Check out our recent blog outlining some key considerations when developing your clinical development plan

Differences in perspectives often lead to better ideas and outcome. Couldn’t agree more with the article on the impact that could result from symbiotic relationship between academics and Pharma companies to speed up the discovery of life saving therapies. Experts from Pharma can do more by being a mentor to academia or start-up to share industry challenges and provide the space for innovations to be tested. #pharma #industry #academia #development #collaboration #partnerships

Innovation insights below on how to boost sustainable, value-creating medicines for patients. To quote: “Process simplification, and automation, along the critical path has gradually come into focus in recent years as the industry races to get medicines to patients faster. Examples of value chain steps where we have observed material accelerations include preclinical candidate nomination to the first subject in (in which we have seen accelerations from 21 to 26 months to 12 to 15 months following optimization), enrollment (20 percent acceleration observed), and submissions (in which actors are increasingly delivering less than eight weeks from database lock to submission).” Achieving these accelerations, the authors write, requires both embedding novel automation and technological solutions and absolute operational clarity on the critical path—and the accountabilities for each process step (often across functional silos) to sustainably boost performance. https://lnkd.in/gz29bHw7

When you're working with an eCOA platform and library, you want to ensure that you're reducing timelines for your clinical trial as much as possible. In this case study, explore how a large pharmaceutical company was able to work with the IQVIA eCOA library to decrease startup timelines by 50%. https://bit.ly/3IsyWVK #eCOA #ClinicalTrials

Universities and pharma companies need each other to create world-changing medicines! 🔬🎓 👩🔬👨🔬 Collaboration between academia and pharma holds an immense potential, but varying intentions can create challenges. Academia thrives on innovation, while pharma often prioritizes profits and scalability. Closer partnerships, dynamic approaches, and mutual understanding are essential for translating groundbreaking academic discoveries into impactful treatments. 🚀 #pharma #industry #academia #development #collaboration #partnerships

Cutting-edge laboratories are revolutionizing innovation and competitiveness. 🌟 Building next-gen pharma labs is key to meeting the demand for innovative therapies, cutting costs, and speeding up approvals. 💊 Check out the latest report by #CapgeminiResearch Institute to learn how industry leaders are investing in lab transformation initiatives to shape the future of medicine. 🚀 #capgemini #medicine #future

In the fast-evolving world of pharma and biotech, decentralized clinical trials (DCTs) are emerging as a game-changer. As we move towards a more patient-centric approach, DCTs represent the future of clinical research, offering a promising avenue to overcome traditional challenges and bring innovative therapies to those who need them most. Read more about the transformative impact of DCTs here: https://lnkd.in/gaDVAegE #ClinicalResearch #DecentralisedTrials #Innovation